First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years’ experience-Reference-Cited by-同舟云学术

First-line immunosuppressive therapy with rATG and CsA for severe aplastic anemia: 15 years’ experience

Published:2022-09-24 Issue:11 Volume:101 Page:2405-2412
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Hu Jing,Zhang Li,Zhao Xin,Liu Xu,Jing Liping,Zhou Kang,Li Yuan,Li Yang,Li Jianping,Ye Lei,Peng Guangxin,Fan Huihui,Yang Wenrui,Yang Yang,Xiong Youzhen,Song Lin,Zhang Fengkui^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-022-04952-2.pdf

Reference31 articles.

1. Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, Young NS (2006) The epidemiology of aplastic anemia in Thailand. Blood 107(4):1299–1307. https://doi.org/10.1182/blood-2005-01-0161

2. Montane E, Ibanez L, Vidal X, Ballarin E, Puig R, Garcia N, Laporte JR, Catalan Group for Study of A, Aplastic A (2008) Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica 93(4):518–523. https://doi.org/10.3324/haematol.12020

3. Young NS, Kaufman DW (2008) The epidemiology of acquired aplastic anemia. Haematologica 93(4):489–492. https://doi.org/10.3324/haematol.12855

4. Zhu XF, He HL, Wang SQ, Tang JY, Han B, Zhang DH, Wu LQ, Wu DP, Li W, Xia LH, Zhu HL, Liu F, Shi HX, Zhang X, Zhou F, Hu JD, Fang JP, Chen XQ, Ye TZ, Liang YM, Jin J, Zhang FK (2019) Current treatment patterns of aplastic anemia in China: a prospective cohort registry study. Acta Haematol 142(3):162–170. https://doi.org/10.1159/000499065

5. Scheinberg P (2021) Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries. Br J Haematol 194(6):954–969. https://doi.org/10.1111/bjh.17403

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse and transformation to myelodysplastic syndrome and acute myeloid leukemia following immunosuppressive therapy for aplastic anemia is more common as compared to allogeneic stem cell transplantation with a negative impact on survival;Annals of Hematology;2024-01-20

2. Predictive value of T cell receptor repertoire profiling for immunosuppressive therapy in severe aplastic anemia;Genes & Diseases;2024-01

3. Development and validation of early death risk score model for emergency status prediction in very severe aplastic anemia;Frontiers in Immunology;2023-04-20

4. Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia;International Immunopharmacology;2023-04

5. Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis−associated aplastic anemia;Frontiers in Immunology;2023-03-17